Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Raphael
W Middleton

Showing results (461-470 of 492) with videos related to

Pageof 50
Sort By:
JAMA|August 28, 1996
Results of radical prostatectomy in men with clinically localized prostate cancerG S Gerber, R A Thisted, P T Scardino, et al.
European Urology|January 1, 1997
Results of radical prostatectomy in men with locally advanced prostate cancer: multi-institutional pooled analysisG S Gerber, R A Thisted, G W Chodak, et al.
Spinal Cord|September 12, 2024
A home-based self-directed EEG neurofeedback intervention for people with chronic neuropathic pain following spinal cord injury (the StoPain Trial): description of the interventionNegin Hesam-Shariati, Lara Alexander, Kevin Yi Chen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2001
Gorillas with spondyloarthropathies express an MHC class I molecule with only limited sequence similarity to HLA-B27 that binds peptides with arginine at P2J A Urvater, H Hickman, J L Dzuris, et al.
Technical Innovations & Patient Support in Radiation Oncology|September 30, 2021
A patient decision aid for breast cancer patients deciding on their radiation treatment, no change in decisional conflict but better informed choicesD B Raphael, N S Russell, B Winkens, et al.
The Lancet. Oncology|December 17, 2013
Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trialHugo E R Ford, Andrea Marshall, John A Bridgewater, et al.
JCI Insight|May 17, 2019
Genomic analysis of benign prostatic hyperplasia implicates cellular re-landscaping in disease pathogenesisLance W Middleton, Zhewei Shen, Sushama Varma, et al.
The Australian and New Zealand Journal of Psychiatry|May 7, 2002
The mental health of young people in Australia: key findings from the child and adolescent component of the national survey of mental health and well-beingM G Sawyer, F M Arney, P A Baghurst, et al.
Oncotarget|January 8, 2019
Genomic loss of heterozygosity and survival in the REAL3 trialElizabeth C Smyth, Catherine Cafferkey, Andrea Loehr, et al.
Journal for Immunotherapy of Cancer|May 31, 2025
Circulating immunoregulatory B cell and autoreactive antibody profiles predict lack of toxicity to anti-PD-1 checkpoint inhibitor treatment in advanced melanomaZena N Willsmore, Lucy Booth, Akshay Patel, et al.
Pageof 50

Showing results (461-470 of 492) with videos related to

Sort By:
Pageof 50
JAMA|August 28, 1996
Results of radical prostatectomy in men with clinically localized prostate cancerG S Gerber, R A Thisted, P T Scardino, et al.
European Urology|January 1, 1997
Results of radical prostatectomy in men with locally advanced prostate cancer: multi-institutional pooled analysisG S Gerber, R A Thisted, G W Chodak, et al.
Spinal Cord|September 12, 2024
A home-based self-directed EEG neurofeedback intervention for people with chronic neuropathic pain following spinal cord injury (the StoPain Trial): description of the interventionNegin Hesam-Shariati, Lara Alexander, Kevin Yi Chen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2001
Gorillas with spondyloarthropathies express an MHC class I molecule with only limited sequence similarity to HLA-B27 that binds peptides with arginine at P2J A Urvater, H Hickman, J L Dzuris, et al.
Technical Innovations & Patient Support in Radiation Oncology|September 30, 2021
A patient decision aid for breast cancer patients deciding on their radiation treatment, no change in decisional conflict but better informed choicesD B Raphael, N S Russell, B Winkens, et al.
The Lancet. Oncology|December 17, 2013
Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trialHugo E R Ford, Andrea Marshall, John A Bridgewater, et al.
JCI Insight|May 17, 2019
Genomic analysis of benign prostatic hyperplasia implicates cellular re-landscaping in disease pathogenesisLance W Middleton, Zhewei Shen, Sushama Varma, et al.
The Australian and New Zealand Journal of Psychiatry|May 7, 2002
The mental health of young people in Australia: key findings from the child and adolescent component of the national survey of mental health and well-beingM G Sawyer, F M Arney, P A Baghurst, et al.
Oncotarget|January 8, 2019
Genomic loss of heterozygosity and survival in the REAL3 trialElizabeth C Smyth, Catherine Cafferkey, Andrea Loehr, et al.
Journal for Immunotherapy of Cancer|May 31, 2025
Circulating immunoregulatory B cell and autoreactive antibody profiles predict lack of toxicity to anti-PD-1 checkpoint inhibitor treatment in advanced melanomaZena N Willsmore, Lucy Booth, Akshay Patel, et al.
Pageof 50